Version history

{
  "session_id": "sess_SDA-2026-04-04-SDA-2026-04-04-gap-debate-20260403-222549-20260402_20260412-195337",
  "round_number": 4,
  "agent_persona": "persona-synthesizer",
  "agent_backend": "minimax/MiniMax-M2.7",
  "action": "synthesize",
  "content": "\n\n```json\n{\n  \"ranked_hypotheses\": [\n    {\n      \"rank\": 1,\n      \"title\": \"Microglial State Characterization for Therapeutic Stratification\",\n      \"mechanism\": \"SEA-AD single-nucleus RNA-seq defines disease-associated microglial states that predict responder profiles for TREM2-targeting immunomodulatory trials.\",\n      \"target_gene\": \"TREM2\",\n      \"confidence_score\": 0.75,\n      \"novelty_score\": 0.5,\n      \"feasibility_score\": 0.7,\n      \"impact_score\": 0.8,\n      \"composite_score\": 0.73,\n      \"testable_prediction\": \"snRNA-seq clustering will identify distinct microglial subpopulations in SEA-AD that correlate with TREM2 expression levels and anti-Aβ antibody treatment response.\",\n      \"skeptic_concern\": \"Whether state definitions will meaningfully differ from existing DAM/ARM nomenclature or merely confirm established microglial biology.\"\n    },\n    {\n      \"rank\": 2,\n      \"title\": \"Wildfire PM2.5-Driven AHR Microglial Priming\",\n      \"mechanism\": \"Chronic Pacific Northwest wildfire PM2.5 exposure hyperactivates microglial aryl hydrocarbon receptor (AHR), driving inflammatory cytokine production and a primed baseline state.\",\n      \"target_gene\": \"AHR\",\n      \"confidence_score\": 0.55,\n      \"novelty_score\": 0.75,\n      \"feasibility_score\": 0.45,\n      \"impact_score\": 0.65,\n      \"composite_score\": 0.595,\n      \"testable_prediction\": \"AHR target gene expression (CYP1A1/CYP1B1) will be significantly elevated in SEA-AD microglia compared to cohorts from regions with lower wildfire burden.\",\n      \"skeptic_concern\": \"No established molecular bridge connects AHR activation to TREM2-DAP12 dysregulation; these are independent signaling cascades requiring mechanistic elucidation.\"\n    },\n    {\n      \"rank\": 3,\n      \"title\": \"Lipid Metabolism/DHA Metabolite Signature\",\n      \"mechanism\": \"SEA-AD donors exhibit distinct oxysterol or resolvin signatures that identify omega-3 intervention responders, leveraging a low-risk already-approved intervention.\",\n      \"target_gene\": \"ALOX15\",\n      \"confidence_score\": 0.6,\n      \"novelty_score\": 0.7,\n      \"feasibility_score\": 0.65,\n      \"impact_score\": 0.55,\n      \"composite_score\": 0.63,\n      \"testable_prediction\": \"Targeted lipidomics will reveal cohort-specific resolvin/oxysterol profiles in SEA-AD that correlate with neuroprotection markers and predict omega-3 trial response.\",\n      \"skeptic_concern\": \"Causal direction unclear—whether distinct signatures reflect protective adaptations or maladaptive breakdown products requires experimental validation.\"\n    }\n  ],\n  \"consensus_points\": [\n    \"SEA-AD's single-nucleus resolution provides unique precision for defining microglial subpopulations\",\n    \"Pacific Northwest environmental exposures (wildfire PM2.5) represent a plausible differentiating factor for this cohort\",\n    \"Microglial biology is the highest-impact axis for therapeutic translation in neurodegeneration research\"\n  ],\n  \"dissent_points\": [\n    \"Theorist proposes direct AHR→TREM2-DAP12 mechanistic chain lacking established molecular evidence (Skeptic); Expert rates this as lower priority due to mechanistic uncertainty\"\n  ],\n  \"debate_summary\": \"Theorist's wildfire-driven AHR hypothesis provides a novel environmental mechanism but relies on an unsupported molecular chain to TREM2-DAP12; Skeptic correctly identifies this mechanistic gap, while Expert prioritizes direct microglial state characterization as more translationally actionable. All parties agree SEA-AD's single-nucleus resolution is the cohort's primary differentiator, with microglial biology representing the highest-potential research axis.\"\n}\n```",
  "tokens_used": "907"
}